Speaker(s): 

Emily Brunner, MD, Medical Director of Eosis Recovery in MN - has nothing to disclose.

Moderator(s): Dr Margaret Jarvis MD, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Apply the key clinical takeaways for safely tapering benzodiazepines based upon the Joint Clinical Practice Guidelines for Benzodiazepine Tapering.
• Recognize strategies for patient engagement and shared decision-making during BZD tapering.
• Identify complications associated with rapid BZD discontinuation and how to prevent them.

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Margaret Jarvis, MD, Jessica Sevecke-Hanrahan, PhD, Jessie Goldhirsh, MD, Chloe Williamson, LCSW, Priscilla Riley, LPC, Imad Melhem, MD, and DeAnn Hansum, PA-C have no identified disclosures. 

Content Disclosure: 

This presentation/content is HIPAA compliant. 

Commercial Support for this Session

None